These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36380821)

  • 21. Heparin and protamine titration do not improve haemostasis in cardiac surgical patients.
    Shore-Lesserson L; Reich DL; DePerio M
    Can J Anaesth; 1998 Jan; 45(1):10-8. PubMed ID: 9466020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management.
    Koster A; Fischer T; Praus M; Haberzettl H; Kuebler WM; Hetzer R; Kuppe H
    Anesthesiology; 2002 Oct; 97(4):837-41. PubMed ID: 12357148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of rotational thromboelastometry during cardiopulmonary bypass: A prospective, observational in-vivo study.
    Gronchi F; Perret A; Ferrari E; Marcucci CM; Flèche J; Crosset M; Schoettker P; Marcucci C
    Eur J Anaesthesiol; 2014 Feb; 31(2):68-75. PubMed ID: 23867776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pharmacokinetic Model for Protamine Dosing After Cardiopulmonary Bypass.
    Meesters MI; Veerhoek D; de Jong JR; Boer C
    J Cardiothorac Vasc Anesth; 2016 Oct; 30(5):1190-5. PubMed ID: 27493093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial.
    Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C
    Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation and autologous blood transfusion in cardiac surgery.
    Inada E
    J Clin Anesth; 1990; 2(6):393-406. PubMed ID: 2271204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized, controlled trial of individualized heparin and protamine management in infants undergoing cardiac surgery with cardiopulmonary bypass.
    Gruenwald CE; Manlhiot C; Chan AK; Crawford-Lean L; Foreman C; Holtby HM; Van Arsdell GS; Richards R; Moriarty H; McCrindle BW
    J Am Coll Cardiol; 2010 Nov; 56(22):1794-802. PubMed ID: 21087706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of allogeneic blood transfusions after open heart operations by lowering cardiopulmonary bypass prime volume.
    Shapira OM; Aldea GS; Treanor PR; Chartrand RM; DeAndrade KM; Lazar HL; Shemin RJ
    Ann Thorac Surg; 1998 Mar; 65(3):724-30. PubMed ID: 9527202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocompatibility of heparin-coated membrane oxygenator during cardiopulmonary bypass.
    Hatori N; Yoshizu H; Haga Y; Kusama Y; Takeshima S; Segawa D; Tanaka S
    Artif Organs; 1994 Dec; 18(12):904-10. PubMed ID: 7887827
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet-activating protamine-heparin-antibodies lead to higher protamine demand in patients undergoing cardiac surgery.
    Grieshaber P; Bakchoul T; Wilhelm J; Wagner A; Wollbrück M; Böning A; Sachs U
    J Thorac Cardiovasc Surg; 2015 Oct; 150(4):967-73.e1. PubMed ID: 26298870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protamine requirements in cardiac surgery: effect of changes in the heparin reference standard.
    Taneja R; Berry L; Pappu U; Stitt L; Sayal P; Allen P; Hoogendoorn H; Chan A
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1227-32. PubMed ID: 25281041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A clinical evaluation of the Hepcon/HMS: a new device of monitoring hemostasis management during cardiopulmonary bypass].
    Yamanishi H; Watanabe S; Hayashi K; Tomioka H; Minami M; Nozaki Y; Aoki T; Kawai Y; Kishino K; Ohta S
    Kyobu Geka; 1997 Jun; 50(6):459-62. PubMed ID: 9185440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Heparin monitoring during cardiopulmonary bypass in congenital heart surgery].
    Isomatsu Y; Imai Y; Seo K; Terada M; Aoki M; Shin'oka T
    Kyobu Geka; 2000 Nov; 53(12):1001-4. PubMed ID: 11079303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of early incomplete heparin reversal following congenital cardiac surgery: A single-center retrospective observational study.
    Magunia H; Schenk S; Schlensak C; Icheva V; Rosenberger P; Straub A; Nowak-Machen M
    Thromb Res; 2019 Oct; 182():33-38. PubMed ID: 31445451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Successful management after cardiopulmonary bypass without administration of protamine in a patient with severe food allergy--beneficial result with the use of heparin-coated bypass circuit].
    Sawai T; Uchida O; Inamori S; Kuro M
    Masui; 2003 Mar; 52(3):280-3. PubMed ID: 12703072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose protamine based on heparin-protamine titration method reduces platelet dysfunction after cardiopulmonary bypass.
    Shigeta O; Kojima H; Hiramatsu Y; Jikuya T; Terada Y; Atsumi N; Sakakibara Y; Nagasawa T; Mitsui T
    J Thorac Cardiovasc Surg; 1999 Aug; 118(2):354-60. PubMed ID: 10425010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management.
    Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T
    J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.